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Abstract 
Background: Cat allergy is of great importance, and its prevalence is increasing worldwide. Cat allergens and house 
dust mite allergens represent the major indoor allergens; however, they are ubiquitous. Cat sensitization and allergy 
are known risk factors for rhinitis, bronchial hyperreactivity and asthma. Thus, the diagnosis of sensitization to cats is 
important for any allergist.
Methods: 70 patients with positive skin prick tests for cats were retrospectively compared regarding their skin prick 
test results, as well as their specific immunoglobulin E antibody profiles with regard to their responses to the native 
cat extract, rFel d 1, nFel d 2 and rFel d 4. 35 patients were allergic to cats, as determined by positive anamnesis and/
or nasal provocation with cat allergens, and 35 patients exhibited clinically non-relevant sensitization, as indicated by 
negative anamnesis and/or a negative nasal allergen challenge.
Results: Native cat extract serology testing detected 100% of patients who were allergic to cats but missed eight 
patients who showed sensitization in the skin prick test and did not have allergic symptoms. The median values of the 
skin prick test, as well as those of the specific immunoglobulin E antibodies against the native cat extract, were signifi-
cantly higher for allergic patients than for patients with clinically non-relevant sensitization. Component based diag-
nostic testing to rFel d 1 was not as reliable. Sensitization to nFel d 2 and rFel d 4 was seen only in individual patients.
Conclusion: Extract based diagnostic methods for identifying cat allergy and sensitization, such as the skin prick test 
and native cat extract serology, remain crucial in routine clinical practice. In our study, component based diagnos-
tic testing could not replace these methods with regard to the detection of sensitization to cats and differentiation 
between allergy and sensitization without clinical relevance. However, component resolved allergy diagnostic tools 
have individual implications, and future studies may facilitate a better understanding of its use and subsequently may 
improve the clinical management of allergic patients.
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Background
There are numerous reasons why sensitization to cats 
plays an important role in the clinical routine of an aller-
gist. First, the prevalence of cat allergy is increasing [1–3]. 
In 2009, a study was published describing sensitization to 
cats in 26% of adults in Europe [4], whereas in 1992, 8.8% 
of adults were sensitized to cats [5]. In German children, 
sensitization to cats is reported in 9.6% of boys and 6.6% 
of girls [6]. Generally, the prevalence of sensitization is 
dependent on age. It increases throughout childhood and 
peaks during adolescence [7–10]. Sensitization to cats is 
associated with increased bronchial hyperresponsiveness 
in adults and children [11–14]. Additionally, cat allergy is 
a major risk factor for developing asthma and rhinitis [15, 
16]. Cat allergens are found in households with cats but 
are also considered ubiquitous. Exposure can occur in 
schools, occupational environments and outdoors [17]. 
The amount of cat allergen in schools correlates directly 
with the number of school children with cats in their 
homes [18]. In homes without a cat, sensitization can 
occur if a sufficient number of households in the com-
munity own a cat. Additionally, pet ownership differs 
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among countries, e.g., 15% of German households have 
cats, whereas in Greece only 4% of households, and in the 
Netherlands 27% own cats [19].
Therefore, the diagnosis of sensitization to cats is 
important, irrespective of cat ownership. There is a trend 
toward costly component resolved analysis, which has 
been described as the beginning of new era in the diag-
nosis of allergies [20, 21], compared to standard diagnos-
tic approaches, such as the extract based SPT (skin prick 
test) and serology against native extract. These standard 
tools are more cost effective because the extract usu-
ally contains all of the allergenic components within one 
test; however, the increased regulatory demands within 
the European Union for any allergen solution used for 
diagnostic tests, such as SPT or provocation tests, have 
driven the use of component resolved analysis [22].
Konradsen et  al. provided a detailed overview of the 
potential of molecular based diagnostic methods in diag-
nosing allergies to furry animals [23]. Briefly, dander is 
considered the primary source of cat allergens [24, 25]. 
The major cat allergen is Fel d 1, a uteroglobin, which was 
purified by Ohman et al.  in 1974 [26]. It is produced in 
the skin and salivary glands [24, 27, 28] and is the sen-
sitizing allergen in up to 95% [29–32]. The characteriza-
tion of many other allergens followed this one. The most 
important are serum albumin Fel d 2 [33, 34], which is 
important for cross-reactivity to serum albumins of other 
animals, and lipocalin Fel d 4 [35], which cross-reacts 
with lipocalin allergens from other animals [12, 36]. Fur-
ther cat allergens have also been characterized, such as 
cystatin Fel d 3 [37], cat IgA Fel d 5 and IgM Fel d 6 [38], 
lipocalin Fel d 7 and latherin-like Fel d 8 [39].
The aim of the study was to investigate whether cat 
allergen component analysis can replace or add anything 




The allergy database of the Department of Oto-Rhino-
Laryngology, Head and Neck Surgery of the Ludwig-
Maximilians-University in Munich consists of patient 
information stated in the case history and diagnostic 
results. The database was retrospectively scanned for 
patients presenting to our department between 2011 and 
2015 with possible cat allergy or sensitization. Within 
these 5  years, a total of 1202 patients underwent com-
prehensive allergy diagnostic testing, and 413 (34%) 
were sensitized against cats. Only a small set of these 
data records were complete with regard to the relevant 
parameters of our study. 70 patients with proven allergy 
(n =  35) or clinically silent sensitization (n =  35) were 
selected. The selection criteria for the allergy group were 
as follows: a positive SPT to cats and positive anamnesis 
for cat allergy and/or a positive nasal allergen challenge. 
For the sensitization group, the criteria were as follows: 
a positive SPT to cats and negative anamnesis for cat 
allergy and/or a negative nasal challenge. The exclusion 
criteria were a combination of an SPT to cats of I and 
a CAP class of 0 for the specific antibody to native cat 
extract using the FEIA (Fluorescence Enzyme Immuno-
assay) method (UniCAP-FEIA, Thermo Fisher Scientific, 
Freiburg, Germany). These patients were rated as not 
sensitized to cats.
Skin prick test (SPT)
The SPT solution for cats by ALK-Abelló, Wedel, Ger-
many was used. The SPT was considered positive with a 
wheal >3 mm in diameter (I = ≥3 to <4, II = ≥4 to <5, 
III = ≥5 to <6, IV = ≥6) in combination with Histamine 
dihydrochloride solution at 1  mg/ml as positive control 
and allergen-free saline solution as negative control. It 
was read 20 min after application. The procedure was in 
line with published guidelines [40–43].
Fluorescence enzyme immunoassay (FEIA)
IgE reactivity to purified natural allergen extract and 
allergen components was measured using the FEIA 
method (UniCAP-FEIA, Thermo Fisher Scientific, 
Freiburg, Germany) with a commercially available test kit 
(Thermo Fisher Scientific, Freiburg, Germany), in accord-
ance with the instructions of the manufacturer. Total IgE 
and specific IgE antibodies to native cat extract and to the 
allergen components rFel d 1, nFel d 2, and rFel d 4 were 
measured. In addition, in patients with positive specific 
IgE towards serum albumin nFel d 2 and lipocalin rFel d 
4, specific IgE to rCan f 2, rCan f 1, nCan f 3 and rEqu 
c 1 were determined, respectively. The results are given 
in concentration units (kU/l). The positive cutoff value 
was >0.35 kU/l as suggested by Thermo Fisher Scientific 
(Freiburg, Germany).
Nasal provocation test
The intranasal challenge test solution for cats designated 
for nasal provocation was glycerin-free and had an aller-
gen concentration of 100,000 SQ-E/ml (ALK-Abelló, 
Wedel, Germany). The intranasal challenge was per-
formed in accordance with the current guidelines [44]. 
Testing was considered positive if rhinomanometry was 
decreased >40% at 150  Pa on the side tested with the 
allergen, as well as for a symptom score >3 or a decrease 
in rhinomanometry >20% in combination with a symp-
tom score >2. The symptom score consists of registered 
secretion, irritation and remote symptoms [45]. The nasal 
provocation test was used to differentiate between allergy 
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and sensitization without clinical relevance in selected 
patients.
Statistical analyses
Statistical analyses and the graphical presentation were 
performed on a Lenovo Thinkpad X61 s with SigmaPlot 
(Jandel Corp., San Rafael, CA, USA) and Excel (Micro-
soft, Redmond, WA, USA). All of the data failed nor-
mality testing (Shapiro–Wilk). Therefore, we used the 
median for descriptive statistics and the Mann–Whitney 
Rank Sum Test for testing statistically significant dif-
ferences in the median values between the two groups. 
For the graphical presentation of the native cat extract 
results, the data are presented as the median with the 
75th percentile as the error bar. Correlation between 
native cat extract and rFel d 1 results was calculated by 
Spearman Rank Order Correlation. A value of p  <  0.05 
was considered significant.
Results
We compared two groups of 35 patients each, one with 
cat allergy and the other with sensitization to cat aller-
gens without clinical relevance. Patient data is summa-
rized in Table 1.
Briefly, both groups were comparable with regard to 
their gender distribution, age and sensitization profiles. 
We distinguished between patients, mono-sensitized to 
cat, patients that were oligo-sensitized to 1–2 additional 
perennial or seasonal allergens, and patients, poly-sen-
sitized to 3 or more allergens in addition to cat. Neither 
group showed any statistically significant differences in 
total IgE antibody concentrations. The allergy group had 
a median total IgE antibody concentration of 188  kU/l, 
and the sensitization group had a median concentra-
tion of 228 kU/l. 36% of all patients reported asthma (18 
(51%) in the cat allergy group and 7 (20%) in the sensi-
tization group). An allergic reaction to food, mainly Bet 
v 1-homologous PR10-protein containing food, was 
reported by 33% of patients [14 (40%) in the allergy group 
and 9 (26%) in the sensitization group]. Allergic symp-
toms with meat were not reported.
We compared different diagnostic tools within the 
allergy and sensitization groups. Figure 1 shows the dis-
tribution of the SPT results in both groups. The mean 
values of the SPT were III (range I–IV) in the sensitiza-
tion group and IV (range II–IV) in the allergy group. This 
difference was statistically significant (p = 0.004).
Table 2 shows the sensitization profiles to different cat 
components of allergic and asymptomatic patients.
Prevalence of a specific IgE against native cat extract 
was 100% in the allergy group and 77% in the sensitiza-
tion group. The 8 patients (23%) who were negative for 
the native extract in the sensitization group had differ-
ent SPT results. 3 of those patients had an SPT of II, 3 
patients had an SPT of III and 2 patients had an SPT of 
Table 1 Patient demographics and characteristics
Values are number of patients total and percent of each evaluated group
Age is given as a mean
Sensitization Allergy
(n = 35) (n = 35)
Male 18 (51%) 15 (43%)
Female 17 (49%) 20 (57%)
Age (range 8–86 years) 35 33
Mono-sensitized 1 (3%) 2 (6%)
Oligo-sensitized 15 (43%) 17 (49%)
Poly-sensitized 19 (54%) 16 (46%)
Asthma 7 (20%) 18 (51%)
Food allergy 9 (26%) 14 (40%)
Fig. 1 Results of SPT. Levels of SPT reactivity (I–IV) in patients with 
clinically silent sensitization (n = 35) and allergy (n = 35) to cat. The 
median in the allergy group is higher than in the sensitization group 
(p = 0.004)
Table 2 Sensitization profile to different cat components
Values are number of patients total and percent of each evaluated group
IgE levels are given as median and range
Sensitization Allergy
(n = 35) (n = 35)
Native cat positive 27 (77%) 35 (100%)
IgE level (kU/l) 1.58 (0.02–82.4) 2.95 (0.5–47.5)
rFel d 1 positive 26 (74%) 32 (91%)
IgE level (kU/l) 1.08 (0.02–53.9) 2.59 (0.18–20.4)
nFel d 2 positive 1 (3%) 2 (6%)
IgE level (kU/l) 0.00 (0–15.5) 0.01 (0–5.66)
rFel d 4 positive 5 (14%) 6 (17%)
IgE level (kU/l) 0.03 (0–36.5) 0.03 (0–12.9)
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IV. The prevalences of rFel d 1, nFel d 2 and rFel d 4 were 
91, 6, and 17% in the allergy group and 74, 3 and 14% 
in the sensitization group. Comparing the 2 groups, we 
found a statistically significant difference in the median of 
the specific IgE antibody concentration toward the native 
cat extract. The median in the allergy group was 2.95 kU/l 
(range 0.5–47.5  kU/l), whereas the median in the sen-
sitization group was 1.58 kU/l (range 0.02–82.4  kU/l) 
(p =  0.012) (Fig.  2). Comparing the median of the spe-
cific IgE antibodies against rFel d 1, we did not find a sta-
tistically significant difference between the groups. The 
median in the allergy group was 2.59  kU/l (range 0.18–
20.4 kU/l), and in the sensitization group, it was 1.08 kU/l 
(range 0.02–53.9 kU/l) (p = 0.07). 93% of patients having 
specific IgE against rFel d 1 also had specific IgE towards 
native cat extract, whereas only one patient having spe-
cific IgE against rFel d 1 did not have specific IgE towards 
native cat extract. This patient was not allergic to cat. The 
correlation between rFel d 1 and native cat extract was 
highly significant (coefficient = 0.896 with p < 0.001). The 
low prevalences of specific IgE antibodies toward nFel d 
2 and rFel d 4 did not allow any assumptions regarding 
differentiation between allergy and silent sensitization 
with respect to these parameters. Figure 3 illustrates the 
distribution of all cat components analysed: out of 58 
patients having specific IgE against rFel d 1, 11 also had 
IgE towards rFel d 4. Out of these 11 patients, 3 patients 
also had specific IgE to nFel d 2 (Fig. 3). 6 of 11 patients 
(55%, 3 allergic, 3 asymptomatic) with specific IgE anti-
bodies to rFel d 4 reported asthma. 2 of these asthmatic 
patients also had specific IgE antibodies to nFel d 2.
Regarding cross-reactivity between serum albumins 
and lipocalins, additional specific IgE antibody testing 
revealed that out of 70 patients, all 3 patients tested posi-
tive for IgE antibodies toward nFel d 2, cat serum albu-
min, also had specific IgE antibodies toward nCan f 3, 
dog serum albumin. 1 of these patients had documented 
subjective allergic symptoms to dogs as well as to cats. 11 
of 70 patients had specific IgE antibodies toward lipoca-
lin rFel d 4. Eight of these patients were also positive for 
IgE antibodies against horse lipocalin rEqu c 1, although 
only two of these patients documented subjective allergic 
symptoms to horse, and only one of them also reported 
clinical symptoms when exposed to cats. Four of the 
11 patients who tested positive for rFel d 4 also had IgE 
antibodies against dog lipocalin rCan f 1. Two of these 
patients were also sensitized to dog lipocalin rCan f 2. 
Three of these patients had documented subjective aller-
gic symptoms when exposed to dogs and cats. None of 
our patients reported allergic symptoms with pork or 
meat.
Discussion
This study examines whether component resolved diag-
nostic testing with rFel d 1, nFel d 2 and rFel d 4 in cat 
allergy can replace or add anything to the performance of 
extract based diagnostic analysis with SPT and serology 
against native cat extract in routine clinical practice.
The SPT is highly sensitive for detecting sensitiza-
tion to native cat allergens. Patients in both groups were 
selected with a positive SPT. Pesonen et al. showed that 
100% of children with positive SPT results also tested 
positive later in life [46]. Nevertheless, there are cases, 
such as children, pre-medicated patients or dermato-
graphic patients, where the SPT is not the primary test 
of choice. Specific IgE antibodies to native cat extract 
also have relatively high sensitivity. In our study, 89% of 





































Fig. 2 Specific IgE concentrations to native cat extract. Median 
specific IgE concentrations in response to native cat extract (in 
kU/l) in patients with clinically silent sensitization and allergy to cat 
(*p = 0.012), with the 75th percentile as the error bar
rFel d 1  
(n = 58) 
rFel d 4  
(n = 11) 
nFel d 2  
(n = 3) 
Fig. 3 Prevalence of specific IgE antibodies toward rFel d 4 and n Fel 
d 2. The prevalence of specific IgE antibodies toward rFel d 4 and n 
Fel d 2 are low. Out of all 70 patients 58 had specific IgE antibodies 
toward r Fel d 1, 11 of these were also positive for r Fel d 4. Of these, 3 
patients also had specific IgE antibodies against nFel d 2
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However, only 77% of the sensitized group had IgE anti-
bodies to native cat extract, whereas in the allergy group, 
specific IgE antibodies to native cat extract were present 
in all patients. Consequently, in our study, native extract 
serology missed one sensitized patient without clinical 
symptoms but was able to reliably detect sensitization in 
an allergic patient. In addition, in our study, the level of 
SPT positivity, as well as the concentration of specific IgE 
toward native cat extract, may indicate the existence of an 
allergy to cats. Allergic patients had a significantly higher 
result in both extract based diagnostic approaches com-
pared to sensitized patients without clinical symptoms.
The component resolved diagnostic tests in our study 
were less sensitive. The prevalences of specific antibodies 
for the allergen components rFel d 1, nFel d 2 and rFel d 
4 were 83, 4 and 16% taking both groups together. 91% 
of patients who were allergic to cats reacted to rFel d 1 
in our study. Thus, 9% of allergic patients would have not 
been detected as being sensitized to cats with compo-
nent resolved diagnostic testing alone. In the literature, 
up to 95% of patients with cat allergies have specific IgE 
antibodies to rFel d 1 [26, 29–32]. In our study, the con-
centrations of specific IgE antibodies against rFel d 1 
were higher in the allergy group than in the sensitization 
group, but the difference was not statistically significant. 
Therefore, we could not conclude that rFel d 1 diagnos-
tic analysis is as specific as extract based testing with 
regard to differentiation between cat allergy and clinically 
irrelevant sensitization. However, we could not exclude 
a type 2 error. Also, nasal challenge to cat allergen was 
not performed in all patients. In routine clinical practice, 
especially in poly-sensitized patients, provocation testing 
cannot be performed to test all sensitizations with regard 
to their clinical relevance. If anamnesis of cat allergy is 
evident, patients do not necessarily undergo provocation 
testing. In our study, 16 patients obtained provocation 
testing due to vague anamnesis. However, we could not 
eliminate inaccuracy by false information or interpreta-
tion of symptoms by the patient.
In the literature, the prevalence of reactivity against 
cat serum albumin in sensitized patients, independent of 
clinical relevance, is described as being between 15 and 
25% [32, 47, 48]. Spitzauer et  al. even describe a preva-
lence of up to 30% among cat and dog allergic patients 
with respect to reactivity against the serum albumin of 
cats and dogs [49]. The prevalence of a positive IgE reac-
tion to serum albumin nFel d 2 in our allergic patients 
was 6%. The prevalence of specific IgE antibody concen-
trations against lipocalin rFel d 4 in the literature is also 
much higher than that found in our study. In our study, it 
was 16% for all patients taken together. Smith et al. report 
levels of up to 63% in sensitized patients, although the 
concentration levels in this study were very low [35]. In 
our study, all patients with positive IgE levels against nFel 
d 2 and rFel d 4 were also positive for native cat extract 
and rFel d 1. Sensitization to multiple components 
was seen in six allergic as well as in five asymptomatic 
patients, therefore, sensitization to multiple components 
did not indicate the likelihood of being allergic to cat. 
However, the number of patients also being sensitized to 
nFel d 2 and rFel d 4 were very low.
In summary, in our study, component based diagnostic 
analysis could not replace standard extract based meth-
ods with regard to detecting sensitization to cats or to 
differentiate between allergy and asymptomatic sensi-
tization in sensitized patients. The following question 
remains: what do component resolved diagnostic tests 
add to standard extract based methods?
Konradsen et  al. recently published a review com-
prehensively addressing this question [23]. They stated 
the importance of identifying specific allergen compo-
nents associated with asthma and severe disease. Bjerg 
et al. reported a higher prevalence of asthma in children 
co-sensitized to rFel d1 and rFel d 4 than in children 
sensitized to r Fel d 1 alone [50]. We also saw a higher 
prevalence of reported asthma (55%) in patients with IgE 
reactivity, not only toward rFel d 1, but also toward nFel 
d 2 and/or rFel d 4. On the other hand, only a few asth-
matic patients were tested positive for nFel d 2 and/or 
rFel d 4. Therefore, testing of these 2 components alone 
could not reliably identify asthmatic patients. Wisniewski 
et al. described an association between high levels of IgE 
antibodies to nFel d 2 and rFel d 4 and atopic dermatitis 
in cat-allergic children [51]. In our allergic collective, 33% 
of patients with IgE levels against nFel d 2 and/or rFel d 
4 self-reported atopic dermatitis. In addition, the above 
mentioned authors note the importance of identifying 
clinically relevant sensitizations to cross-reactive mol-
ecules and those associated with allergic syndromes. IgE 
antibodies to nFel d 2, as well as to rFel d 4, are cross-
reactive to serum albumins and lipocalins of other ani-
mals. Spitzauer et  al. showed that a high percentage of 
patients sensitized to serum albumin react to cat and dog 
[49]. This was confirmed in our study; all patients with 
IgE antibodies reactive to cat serum albumin nFel d 2 
also reacted to dog serum albumin nCan f 3. Regarding 
the lipocalins, the sequence identities are usually much 
lower than for serum albumins. This explains the low 
co-prevalence of sensitization to cat lipocalins and dog 
lipocalins in our study. Only a few lipocalins, such as Fel 
d 4 and Equ c 1, show much higher sequence identities of 
approximately 60% [36, 52]. The cross-reactivity between 
the two serum albumins in our study was high, as well. 8 
(73%) of 11 patients having IgE antibodies reactive to rFel 
d 4 also reacted to rEqu c 1. Liccardi et  al. stressed the 
importance of component based diagnostics in detecting 
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allergic sensitization to common pets, such as cats and 
dogs, and their potential usefulness in predicting the 
risk of allergic sensitization to other less common ani-
mals as it has been suggested that cross-reacting mech-
anisms may play a role in this process, especially in the 
absence of any possible direct or indirect contact. They 
argue the use of this approach for the detection of major 
risk factors for severe respiratory disease among sensi-
tized patients without prior animal exposure, especially 
before acquiring a new pet or initiating contact with a pet 
for work or leisure [53]. IgE cross-reactions within the 
serum albumin and lipocalin families, their implications 
for the diagnosis of allergies and their clinical relevance 
are the subject of many research studies. Konradsen 
et al. concluded that there is clear evidence for the clini-
cal importance of component resolved diagnostic test-
ing in specific cases and also defined several topics that 
should be addressed in future to broaden the spectrum 
of the utility of these tests in routine clinical practice with 
regard to sensitization to furry animals [23].
In conclusion, extract based methods, such as the SPT 
and serology to native cat extract, are crucial in routine 
clinical practice for detecting sensitization to cats and 
cannot be replaced by a single allergen component or 
a combination of allergen components, and therefore 
remain the most effective tool for diagnosing sensitization 
to cats. Moreover, in our study, results of SPT and specific 
IgE antibodies against native cat extract were significantly 
higher in patients allergic to cats compared to patients 
without clinical symptoms. This trend could not be seen 
for the allergen components rFel d 1, nFel d 2 and rFel d 4.
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